Back

TLR7 deficiency alleviated myocardial ischemia reperfusion injury via regulating macrophage-neutrophil interaction

30 August 2024 (14:00 - 14:40)
Organised by: Logo
Congress Presentation Part of: Basic research in acute coronary syndromes Reperfusion and Reperfusion Injury ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yanqiu Lai

National University of Singapore, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail
Empagliflozin treatment pre- and post- acute myocardial infarction reduces no-reflow, inflammatory cell infiltration and infarct size while preserving cardiac function.
Doctor P. Nikolaou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Carvedilol suppresses coronary artery spasm in A-kinase anchoring protein 150 knockout mouse
Doctor Y. Konno (Hirosaki, JP)
Abstract Slides Video
Presentation thumbnail
Nonalcoholic fatty liver disease worsens cardiac repair after myocardial infarction
Doctor F. Hamidou (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Mortality related to left ventricular ejection fraction and obstructive coronary artery disease in non-ST-segment elevation myocardial infarction
Doctor N. Stoedkilde-Joergensen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Soluble amyloid precursor protein-alpha mediates post-ischemic neovascularization after myocardial infarction
Doctor H. Kawase (Bad Nauheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Basic research in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Clec4e deletion in cardiac resident cells leads to smaller infarct size and better cardiac remodeling following myocardial ischemia-reperfusion injury
thumbnail
Congress Presentation
Mechanical channel protein Piezo1 mediates macrophage polarization to exacerbate myocardial ischemia-reperfusion injury
thumbnail
Congress Session
Immunomodulation in cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources